Cargando…
Towards identification of true cancer biomarkers
BACKGROUND: Most of newly discovered cancer biomarkers fail in the clinic because they lack sensitivity and/or specificity. The current explosion in knowledge of the mutational spectrum of many cancer types, as a result of whole exome and whole genome sequencing, has revealed a wide spectrum of muta...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161831/ https://www.ncbi.nlm.nih.gov/pubmed/25220599 http://dx.doi.org/10.1186/s12916-014-0156-8 |